Business
Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer
NEWARK, Calif., March 28, 2022 /PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) today announced the appointment of Asif Ali as Executive Vice President
About this update from Protagonist Therapeutics, Inc.
[{"type":"text","content":"NEWARK, Calif., March 28, 2022 /PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) today announced the appointment of Asif Ali as Executive Vice President and Chief Financial Officer (CFO). In this role, Asif's responsibilities will extend across all finance-related functions within the Company, including financial planning and analysis, taxation, accounting and financial reporting, finance operations, investor relations, and strategic partnership-related financings.\n\"I am extremely pleased to welcome Asif to Protagonist as our new CFO,\" said Dinesh V. Patel, Ph.D., President and Chief Executive Officer of Protagonist. \"His track record of success includes leadership and execution of the complex financial aspects of product commercialization, strategic partnerships, and long-term business strategy. His deep industry expertise, combined with his leadership skill and strength of character, make Asif an excellent addition to our executive team. I look forward to working closely with him in fulfilling and further expanding the promise of our clinical product pipeline in support of patients.\"\nAsif will join Protagonist in mid-April. He comes to Protagonist from Theravance Biopharma, where he served as Chief Accounting Officer. At Theravance, Asif's scope of oversight and contributions included equity and asset-backed financings, strategic collaborations, finance operations, and international tax planning. Asif's prior work as Vice President and Controller at Depomed, Inc. included support of five product launches, four successful product acquisitions, and a significant financing from the sale of future royalties.\n\"Protagonist is poised for substantial growth as it continues to advance its robust pipeline of drug candidates,\" Asif stated. \"As someone who has had the opportunity to serve in leadership positions with a number of strong companies, I am especially excited about Protagonist's future potential to deliver value to patients and other stakeholders. I'm thrilled to join this seasoned executive team on the journey ahead.\"\nAbout ProtagonistProtagonist Therapeutics is a biopharmaceutical company with multiple peptide-based new chemical entities in different stages of clinical development, all derived from the Company's proprietary technology platform.\nProtagonist's pipeline includes rusfertide, an investigational,...